Urgent.News

What's breaking now, across thousands of outlets.

World

Explosion rocks ammunition factory near Rome, Italian police say

Italian media reported that there were no casualties, with the AGI news agency saying employees sheltered in secure areas at the facility.

An explosion occurred at an ammunition factory situated near the town of Colleferro, approximately 40 kilometers southeast of Rome, on Friday. According to emergency services and the factory owner, there were no reported injuries in connection with the incident. Firefighters and law enforcement officials responded to the scene in the area, with 10 fire service units dispatched to assist. Initial reports included videos showcasing thick smoke and a significant explosion emanating from the facility.

The ammunition factory, owned by European defense company KNDS, specializes in the production of medium and large-caliber ammunition. KNDS confirmed that no injuries had been reported, stating that the circumstances surrounding the explosion were currently under investigation. Italy's AGI news agency reported that employees had taken refuge in secure areas within the facility.

The Corriere della Sera daily newspaper added that the fire was believed to have originated from a compaction press responsible for processing explosive powder.

Written by urgent.news from Gulf News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at euronews.com →

More in World

Why vital chemotherapy drugs are in short supply in India

Prices for platinum—the core raw material used in cisplatin and carboplatin—more than doubled, making old price-controlled manufacturing rates financially unviable; additionally, shipping constraints through West Asia have restricted raw material imports from global suppliers.

Why vital chemotherapy drugs are in short supply in India

Prices for platinum—the core raw material used in cisplatin and carboplatin—more than doubled, making old price-controlled manufacturing rates financially unviable; additionally, shipping constraints through West Asia have restricted raw material imports from global suppliers.

More from Thursday 13 August →